1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Graves% Ophthalmopathy Global Clinical Trials Review, H2, 2015

Graves' Ophthalmopathy Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Graves' Ophthalmopathy Global Clinical Trials Review, H2, 2015" provides an overview of Graves’ Ophthalmopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Graves’ Ophthalmopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Graves% Ophthalmopathy Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Graves' Ophthalmopathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Graves' Ophthalmopathy 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Graves' Ophthalmopathy Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
River Vision Development Corp. 31
Clinical Trial Overview of River Vision Development Corp. 31
Premier Research Group Limited 32
Clinical Trial Overview of Premier Research Group Limited 32
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
Neothetics, Inc. 34
Clinical Trial Overview of Neothetics, Inc. 34
Ipsen S.A. 35
Clinical Trial Overview of Ipsen S.A. 35
GlaxoSmithKline Plc 36
Clinical Trial Overview of GlaxoSmithKline Plc 36
Genmab A/S 37
Clinical Trial Overview of Genmab A/S 37
Fresenius Biotech GmbH (Inactive) 38
Clinical Trial Overview of Fresenius Biotech GmbH (Inactive) 38
Barwon Health 39
Clinical Trial Overview of Barwon Health 39
Allergan Plc 40
Clinical Trial Overview of Allergan Plc 40
Clinical Trial Overview of Top Institutes / Government 41
Sun Yat-sen University 41
Clinical Trial Overview of Sun Yat-sen University 41
Academic Medical Center 42
Clinical Trial Overview of Academic Medical Center 42
Medical University of Vienna 43
Clinical Trial Overview of Medical University of Vienna 43
Agostino Gemelli University Polyclinic 44
Clinical Trial Overview of Agostino Gemelli University Polyclinic 44
Ankara University 45
Clinical Trial Overview of Ankara University 45
California Pacific Medical Center Research Institute 46
Clinical Trial Overview of California Pacific Medical Center Research Institute 46
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico 47
Clinical Trial Overview of Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico 47
Hospices Civils de Lyon 48
Clinical Trial Overview of Hospices Civils de Lyon 48
Hospital Clinico Universitario Santiago de Compostela 49
Clinical Trial Overview of Hospital Clinico Universitario Santiago de Compostela 49
Institute of Post Graduate Medical Education And Research 50
Clinical Trial Overview of Institute of Post Graduate Medical Education And Research 50
Five Key Clinical Profiles 51
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About GlobalData 72
Contact Us 72
Disclaimer 72
Source 73

List of Tables
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Region, 2015* 7
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Graves' Ophthalmopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Graves' Ophthalmopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Graves' Ophthalmopathy Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Graves' Ophthalmopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Graves' Ophthalmopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Graves' Ophthalmopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Graves' Ophthalmopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Graves' Ophthalmopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Graves' Ophthalmopathy Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Graves' Ophthalmopathy Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Graves' Ophthalmopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by River Vision Development Corp., 2015* 31
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Premier Research Group Limited, 2015* 32
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 33
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Neothetics, Inc. , 2015* 34
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015* 35
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 36
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Genmab A/S, 2015* 37
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Fresenius Biotech GmbH (Inactive), 2015* 38
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Barwon Health, 2015* 39
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015* 40
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 41
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 42
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 43
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Agostino Gemelli University Polyclinic, 2015* 44
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ankara University, 2015* 45
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by California Pacific Medical Center Research Institute, 2015* 46
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, 2015* 47
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2015* 48
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinico Universitario Santiago de Compostela, 2015* 49
Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Post Graduate Medical Education And Research, 2015* 50

List of Figures
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Graves' Ophthalmopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Graves' Ophthalmopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Graves' Ophthalmopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Graves' Ophthalmopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Graves' Ophthalmopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Graves' Ophthalmopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Graves' Ophthalmopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Graves' Ophthalmopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 71

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.